Endogenous Cushing's Syndrome
Endocrinology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
RecordatiOsilodrostat
Clinical Trials (1)
Total enrollment: 206 patients across 1 trials
Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
Start: Jun 2022Est. completion: Aug 2027206 patients
N/AActive Not Recruiting
Related Jobs in Endocrinology
Senior Scientist, Analytical Development
Neurocrine Biosciences
US CA San Diego
Yesterday
$111K - $151K/yr
Clinical Practice Liaison - Psych, Kansas
Neurocrine Biosciences
Kansas City, MO
Yesterday
$161K - $220K/yr
Medical Science Liaison/Sr. Medical Science Liaison
Neurocrine Biosciences
US NC Home Office
Yesterday
$161K - $220K/yr
Principal Scientist, Lead Generation Biology (Head of Biophysics/SPR Lab)
Neurocrine Biosciences
US CA San Diego
2d ago
$131K - $179K/yr
Long Term Care Account Specialist - Oceanside CA
Neurocrine Biosciences
Oceanside CA
2d ago
$123K - $168K/yr
Sr. Clinical Trials Manager
Neurocrine Biosciences
UK London
2d ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space